Joseph Conanan Legaspi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Indianapolis Blvd, Schererville, IN 46375 Phone: 219-440-7373 Fax: 219-836-0355 |
Yasir Fasih, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 W Lincoln Hwy, Schererville, IN 46375 Phone: 219-322-3311 Fax: 219-322-8210 |
Brent Cutro, DO Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 W. Lincoln Highway, Schererville, IN 46375 Phone: 219-322-3311 |
Dr. Teofilo S Vinluan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1217 Us Highway 41, Schererville, IN 46375 Phone: 219-769-6545 |
Mohammed Abdul Raoof Siddiqui, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13 W Us Highway 30, Schererville, IN 46375 Phone: 219-865-0918 Fax: 219-864-8332 |
Gregory Allen Thomas, M.D. Internal Medicine - Bariatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 41 Us Highway 41, Schererville, IN 46375 Phone: 219-765-4720 |
Dr. Asrar A Sheikh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1217 Us Highway 41, Schererville, IN 46375 Phone: 219-440-7351 Fax: 219-227-8920 |
News Archive
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the first-time-in-man Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated and dosing has begun.
AstraZeneca and Isis Pharmaceuticals Inc. today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides.
The New York Times: AstraZeneca has settled a case and agreed to pay $520 million after federal investigations into its marketing practices for a schizophrenia drug, Seroquel. The announcement came Tuesday from Attorney General Eric Holder. Government officials, including Health and Human Services Secretary Kathleen Sebelius, said the company paid illegal kickbacks to doctors to promote drugs for unapproved uses by children, the elderly, veterans and prisoners, which is illegal under federal law.
A University of Colorado Cancer Center study published today in the journal Molecular Cancer Therapeutics shows that only about 1 percent of triple-negative breast cancer cells in a tumor must be "androgen-receptor-positive" to show benefit from anti-androgen therapies.
› Verified 2 days ago